The HIV Impact Network for Vertical Transmission Elimination (HIVE) is a multi-country knowledge-exchange network. HIVE collaborates with ministries of health and partner organizations in the vertical transmission prevention response, including networks of people living with HIV, to advance the coverage and quality of services designed to prevent the vertical transmission of HIV and safeguard the health of pregnant and breastfeeding women, and their infants.
Funded by the Gates Foundation, HIVE leverages the global expertise of ICAP and Paediatric-Adolescent Treatment Africa (PATA) technical staff to coordinate the HIVE project. Together, these global and regional experts facilitate peer-to-peer learning and information exchange and provide network members with technical assistance and tools to optimize vertical transmission elimination.
In 2026, HIVE is sharpening its focus on HIV prevention for pregnant and breastfeeding women.
Against the backdrop of a changing global health landscape, HIVE is placing an emphasis on supporting countries in the network to strengthen HIV testing and identify women at increased risk of HIV acquisition to promote timely linkage to PrEP services. This focus is critical as HIVE-member countries move beyond oral PrEP to introduce long-acting injectable options such as cabotegravir (CAB-LA) and lenacapavir (LEN) within maternal and child health services.
